A carregar...

Advances in hematopoietic cell transplant for the treatment of hematologic malignancies

PURPOSE OF REVIEW: Incorporation of minimal residual disease (MRD) testing in acute lymphoblastic leukemia (ALL) and acute myeloblastic leukemia (AML) has transformed the landscape of hematopoietic cell transplantation (HCT). Pre-HCT MRD has allowed prognostication of HCT outcomes for high-risk leuk...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Opin Pediatr
Main Authors: Taraseviciute, Agne, Pulsipher, Michael A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7461816/
https://ncbi.nlm.nih.gov/pubmed/30585866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOP.0000000000000729
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!